Radially cross-aligned nanofiber membrane
AssigneeUniversity of Central Oklahoma
InventorMaurice Haff
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Central Oklahoma
InventorMaurice Haff
Estimating the term…
A method for controlling fiber cross-alignment in a nanofiber membrane, comprising: providing a multiple segment collector in an electrospinning device including a first and second segment electrically isolated from an intermediate segment positioned between the first and second segment, collectively presenting a cylindrical structure, rotating the cylindrical structure around a longitudinal axis proximate to an electrically charged fiber emitter; electrically grounding or charging edge conductors circumferentially resident on the first and second segment, maintaining intermediate collector electrically neutral; dispensing electrospun fiber toward the collector, the fiber attaching to edge conductors and spanning the separation space between edge conductors; attracting electrospun fiber attached to the edge conductors to the surface of the cylindrical structure, forming a first fiber layer; increasing or decreasing rotation speed of the cylindrical structure to alter the angular cross-alignment relationship between aligned nanofibers in adjacent layers, the rotation speed being altered to achieve a target relational angle.
A fiber membrane, comprising electrospun fiberizeable material in at least three adjacent layers of nanofibers, each layer comprising a plurality of aligned nanofibers oriented at oblique angles relative to nanofibers in adjacent layers, said plurality of aligned nanofibers in each layer extending from a first membrane edge to a second membrane edge, wherein a plurality of aligned nanofibers in each layer cross a plurality of aligned nanofibers in adjacent layers at a plurality of distinct points of intersection, forming a crossing at each distinct point of intersection consisting of three crossing nanofibers extending directionally as six radials from each of said distinct points of intersection, wherein relative cross-alignment angles between said six radials at each distinct point of intersection are in the range of 50 to 70 degrees, and wherein said relative cross-alignment angles of said aligned nanofibers and spacing between said aligned nanofibers each have a specific average numerical value in said membrane and comprise a structure having porosity required for cell migration and exudate flow from a wound, and wherein said aligned nanofibers comprise a polymer and any one or combination of a chromogenic agent, an antimicrobial agent, a hemostatic agent, an analgesic agent, a regenerative agent, an immune modulator, an oxygenating agent, and a pH stabilizer.
A fiber membrane, comprising electrospun fiberizeable material in at least three adjacent layers of nanofibers, each layer comprising a plurality of aligned nanofibers oriented at oblique angles relative to nanofibers in adjacent layers, said plurality of aligned nanofibers in each layer extending from a first membrane edge to a second membrane edge, wherein a plurality of aligned nanofibers in each layer cross a plurality of aligned nanofibers in adjacent layers at a plurality of distinct points of intersection, forming a crossing at each distinct point of intersection consisting of three crossing nanofibers extending directionally as six radials from each of said distinct points of intersection, wherein relative cross-alignment angles between said six radials at each distinct point of intersection are in the range of 50 to 70 degrees, and wherein said relative cross-alignment angles of said aligned nanofibers and spacing between said aligned nanofibers each have a specific average numerical value in said membrane, and wherein said aligned nanofibers in each said layer comprise at least one of solid, hollow, or core-shell fiber, and wherein said nanofibers further comprise a polymeric material and a chromogenic agent responsive to enzymatic activity, and wherein said polymeric nanofibers further comprise an absorbable and biodegradable polymer that can be is-enzymatically or nonenzymatically decomposed, yields no toxic decomposition product, and has ability of releasing a drug.
Dependencies are inferred from the claim text.